Last reviewed · How we verify

NCT04902924

Cold and Warm Water for Performance Recovery

Completed NA Results posted Last updated 7 October 2025
What this trial tests

NA trial testing repeated cold water therapy in Healthy in 30 participants. Completed in 1 May 2022.

Timeline
1 October 2021
Primary endpoint
30 April 2022
1 May 2022

Quick facts

Lead sponsorUniversity of Applied Sciences and Arts of Southern Switzerland
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment30
Start date1 October 2021
Primary completion30 April 2022
Estimated completion1 May 2022
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University of Applied Sciences and Arts of Southern Switzerland

Who can join

Adults 18 to 35, female only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Maximum Voluntary Isometric Contraction (N) Primary · baseline to 72 hours

maximun voluntary isometric contraction of the knee extensor muscle will be assessed.

BL
GroupValue95% CI
Repeated Cold-water Immersion54.8± 14.9
Repeated Warm-water Immersion65.8± 11.6
Control52.2± 14.1
24h
GroupValue95% CI
Repeated Cold-water Immersion33.8± 13.9
Repeated Warm-water Immersion41.1± 11.4
Control29.3± 8.7
48h
GroupValue95% CI
Repeated Cold-water Immersion41.8± 16.4
Repeated Warm-water Immersion47.9± 10.3
Control34.7± 12.3
72h
GroupValue95% CI
Repeated Cold-water Immersion45.0± 17.0
Repeated Warm-water Immersion54.5± 11.8
Control40.4± 13.2
Delayed Onset of Muscle Soreness (DOMS) Primary · baseline to 72 hours

delayed onset of muscle soreness will be measured using a 0-10 scale, where 0 indicated no soreness and 10 indicates maximum soreness of the knee extensor muscles

BL
GroupValue95% CI
Repeated Cold-water Immersion0.1± 0.1
Repeated Warm-water Immersion0.1± 0.1
Control0.1± 0.1
24h
GroupValue95% CI
Repeated Cold-water Immersion6.3± 2.6
Repeated Warm-water Immersion6.1± 2.5
Control6.3± 2.7
48h
GroupValue95% CI
Repeated Cold-water Immersion5.0± 2.8
Repeated Warm-water Immersion5.9± 3.0
Control6.1± 3.1
72h
GroupValue95% CI
Repeated Cold-water Immersion2.9± 2.6
Repeated Warm-water Immersion4.6± 3.1
Control3.3± 2.3
Muscle Swelling Primary · baseline to 72 hours

swelling of the knee extensor muscle will be performed using a ultrasound device.

BL
GroupValue95% CI
Repeated Cold-water Immersion4.3± 0.5
Repeated Warm-water Immersion4.8± 0.6
Control4.6± 0.5
24h
GroupValue95% CI
Repeated Cold-water Immersion4.6± 0.5
Repeated Warm-water Immersion5.2± 0.6
Control4.8± 0.6
48h
GroupValue95% CI
Repeated Cold-water Immersion4.5± 0.5
Repeated Warm-water Immersion5.1± 0.5
Control4.7± 0.6
72h
GroupValue95% CI
Repeated Cold-water Immersion4.4± 0.5
Repeated Warm-water Immersion5.0± 0.6
Control4.6± 0.6
Creatine-kinase (U/l) Primary · baseline to 72 hours

using a blood sample (6 ml), creatine-kinase will be assessed

BL
GroupValue95% CI
Repeated Cold-water Immersion111.0± 41.5
Repeated Warm-water Immersion214.3± 180.9
Control119.8± 50.2
24h
GroupValue95% CI
Repeated Cold-water Immersion573.5± 488.9
Repeated Warm-water Immersion820.6± 517.7
Control455.0± 318.2
48h
GroupValue95% CI
Repeated Cold-water Immersion335.4± 256.9
Repeated Warm-water Immersion441.2± 349.2
Control288.3± 200.9
72h
GroupValue95% CI
Repeated Cold-water Immersion205.9± 146.2
Repeated Warm-water Immersion314.3± 321.8
Control191.4± 118.1
Muscle Blood Oxygenation Primary · through recovery intervention up to 30 minutes

Muscle oxygenation saturation (SmO2) of the knee extensor muscle will be measured using near-infrared spectroscopy device. Oxygenated haemoglobin (oxyHb), deoxygenated haemoglobin (deoxyHb) and total haemoglobin (TotHb) were assessed in arbitrary units and SmO2 was calculated as oxyHb/TotHb x 100 value (%)

BL
GroupValue95% CI
Repeated Cold-water Immersion68.7± 4.4
Repeated Warm-water Immersion68.8± 3.8
Control70.0± 3.7
post exercise
GroupValue95% CI
Repeated Cold-water Immersion70.4± 7.7
Repeated Warm-water Immersion71.1± 7.1
Control73.4± 5.9
post Intervention
GroupValue95% CI
Repeated Cold-water Immersion76.6± 5.8
Repeated Warm-water Immersion76.6± 3.4
Control74.0± 4.8
10min
GroupValue95% CI
Repeated Cold-water Immersion73.6± 5.3
Repeated Warm-water Immersion75.5± 5.1
Control75.0± 5.4
20min
GroupValue95% CI
Repeated Cold-water Immersion67.8± 2.7
Repeated Warm-water Immersion74.7± 3.2
Control73.5± 6.6
30min
GroupValue95% CI
Repeated Cold-water Immersion64.4± 6.4
Repeated Warm-water Immersion74.4± 3.9
Control73.0± 6.1
Skin Temperature (°C) Primary · through recovery intervention up to 30 minutes

Skin temperature will be measured using a near infrared thermography camera

BL
GroupValue95% CI
Repeated Cold-water Immersion30.6± 0.9
Repeated Warm-water Immersion31.2± 1.1
Control30.9± 0.9
post Exercise
GroupValue95% CI
Repeated Cold-water Immersion30.0± 0.9
Repeated Warm-water Immersion29.9± 1.0
Control29.5± 1.7
post Intervention
GroupValue95% CI
Repeated Cold-water Immersion15.2± 2.5
Repeated Warm-water Immersion35.2± 0.7
Control31.8± 1.0
10min
GroupValue95% CI
Repeated Cold-water Immersion24.8± 1.2
Repeated Warm-water Immersion35.3± 0.5
Control32.3± 0.8
20min
GroupValue95% CI
Repeated Cold-water Immersion27.9± 1.1
Repeated Warm-water Immersion34.9± 0.5
Control32.4± 0.8
30min
GroupValue95% CI
Repeated Cold-water Immersion29.2± 1.0
Repeated Warm-water Immersion34.8± 0.7
Control32.5± 0.9
Core Temperature (°C) Primary · through recovery intervention up to 30 minutes

core temperature will be measured using temperature pill that will provide real time values from the gastrointestinal region

BL
GroupValue95% CI
Repeated Cold-water Immersion37.1± 0.4
Repeated Warm-water Immersion37.1± 0.2
Control36.8± 0.4
post Exercise
GroupValue95% CI
Repeated Cold-water Immersion38.5± 0.2
Repeated Warm-water Immersion38.4± 0.3
Control38.3± 0.2
post Intervention
GroupValue95% CI
Repeated Cold-water Immersion37.9± 0.2
Repeated Warm-water Immersion38.5± 0.3
Control37.9± 0.3
10 min
GroupValue95% CI
Repeated Cold-water Immersion37.6± 0.2
Repeated Warm-water Immersion37.8± 0.2
Control37.5± 0.2
20 min
GroupValue95% CI
Repeated Cold-water Immersion37.3± 0.2
Repeated Warm-water Immersion37.5± 0.2
Control37.3± 0.2
30 min
GroupValue95% CI
Repeated Cold-water Immersion37.2± 0.2
Repeated Warm-water Immersion37.5± 0.2
Control37.2± 0.1

Sponsor's own description

The overall aim of this study is, to evaluate the effectiveness of repeated cold- and warm water immersion on performance recovery after muscle damage.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. No acceleration of recovery from exercise-induced muscle damage after cold or hot water immersion in women: A randomised controlled trial.
    Wellauer V, Clijsen R, Bianchi G, Riggi E, et al · · 2025 · cited 1× · PMID 40333546 · DOI 10.1371/journal.pone.0322416
  2. Acute physiological responses and muscle recovery in females: a randomised controlled trial of muscle damaging exercise in hypoxia.
    Hohenauer E, Bianchi G, Wellauer V, Taube W, et al · · 2024 · PMID 38520001 · DOI 10.1186/s13102-024-00861-1

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University of Applied Sciences and Arts of Southern Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04902924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing